Using autonomous electrostimulation device «Erektron» in treating female overactive bladder


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction: Overactive bladder (OAB) is one of the most common syndromes of lower urinary tract dysfunction. Besides standard therapy using anticholinergic medications, comprehensive management of overactive bladder includes physiotherapy. Aim: To test the clinical effectiveness and safety of autonomous electrostimulation device «Erektron» in treating OAB in women. Materials and Methods: The study was conducted at the Urology and Gynecology Clinic of the Innovative Medical Technology Center between 25.04.2014 and 30.01.2015. It included 20 women with newly diagnosed OAB both with and without urinary urgency incontinence or urinary stress incontinence. The patients were divided into 2 groups. All patients were treated with the first line anticholinergic agent solifenacin 5 mg daily. In patients of group 1, anticholinergic therapy was administered concurrently with intravaginal electrostimulation using «Erektron» device. Results: In both groups, the treatment resulted in positive results, but a more pronounced improvement was found in group 1 patients with mixed incontinence. Conclusion. Autonomous electrostimulation device MT-RV «Erektron» can be used in comprehensive management of patients with OAB, including those with stress urinary incontinence.

Full Text

Restricted Access

About the authors

G. Yu Yarin

Tsiv’yan Novosibirsk Research Institute of Traumatology and Orthopedics; Innovative Medical Technology Center, ANO «Clinic NIITO»

Email: yaringennadiy@icloud.com
PhD

O. V Shelyakina

Tsiv’yan Novosibirsk Research Institute of Traumatology and Orthopedics; Innovative Medical Technology Center, ANO «Clinic NIITO»

V. N Fedorenko

Innovative Medical Technology Center, ANO «Clinic NIITO»

A. V Alekseeva

Innovative Medical Technology Center, ANO «Clinic NIITO»

I. A Vil’gel’mi

Innovative Medical Technology Center, ANO «Clinic NIITO»

References

  1. Пушкарь Д.Ю., Щавелева О.Б. Гиперактивный мочевой пузырь: эпидемиология, диагностика, сравнительная оценка медикаментозной терапии. Фарматека. 2004;16:26
  2. Irwin D., Milsom I., Kopp Z. et al. Overactive bladder symptom prevalence and health-care-seeking behaviour among men in 6 European countries. Eur Urol. 2005;4(Suppl. 3):60.
  3. Milsom I., Abrams P., Cardozo L., Roberts R.G., Thuroff J., Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001;87:760-766.
  4. Stewart W.F., Corey R., Herzog A.R. et al. Prevalence of overactive bladder in women: results from the NOBLE program. Int Urogynecol J. Pelvic Floor Dysfunct. 2001;12:S66.
  5. Abrams P., Cardozo L., Fall M. et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn, 2002;21:167-178.
  6. Schroder A., Chichtster P., Kogan B.A. et al. Effect of chronic bladder outlet obstruction on the blood flow of the urinary bladder. J. Urol. 2001;165:640-646.
  7. Stewart W.F. Prevalence and burden of overactive bladder in the United States. World J. Urol. 2003;20:327.
  8. Appell R.A. Electrical stimulation for the treatment of urinary incontinence. Urology. 1998;51(Suppl. 2A):24-26.
  9. Kegel A. Physiologic therapy for urinary stress incontinence. J. Am. Med. Assoc. 1951;146:915-917.
  10. Brubaker L. Electrical stimulation in over-active bladder. Urology. 2000;55(Suppl. 17):23-31.
  11. Kafri R., Deutscher D., Shames J., Golombp J., Melzer I. Randomized trial of a comparison of rehabilitation or drug therapy for urgency urinary incontinence: 1-year follow-up. Int Urogynecol J. 2013;24(7):1181-1189.
  12. Jerez-Roig J., Souza D.L., Espelt A., Costa-Marin M., Belda-Molina A.M. Pelvic floor electrostimulation in women with urinary incontinence and/or overactive bladder syndrome: a systematic review. Actas Urol Esp. 2013;37(7):429-444.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies